[Remote] Senior Clinical Trial Manager- APAC at Abata Therapeutics

Remote

Abata Therapeutics Logo
Not SpecifiedCompensation
N/AExperience Level
N/AJob Type
Not SpecifiedVisa
N/AIndustries

Requirements

  • Minimum 5 years of experience in clinical trial management, preferably in a pharmaceutical or biotechnology company
  • Strong understanding of clinical trial regulations, including ICH/GCP and regulatory compliance
  • Experience in managing cross-functional teams, including CRO/vendor partners and external service providers
  • Proven track record of leading and managing clinical trials, with a focus on quality and efficiency
  • Strong analytical and problem-solving skills, with the ability to identify and mitigate risks
  • Excellent communication and interpersonal skills, with the ability to interact with internal and external stakeholders
  • Experience with scenario planning, risk benefit analyses, and models of performance excellence
  • Strong understanding of clinical trial protocols, study and development plans, and department-level SOPs
  • Experience with clinical data review and submission activities
  • Fluency in English and Mandarin

Responsibilities

  • Manage and support internal and external clinical operations resources
  • Contribute to strategy, tactics, and driving execution of global clinical studies
  • Influence, manage, and lead planning, budgeting, and study management processes in global clinical studies
  • Accountable for oversight and management of CRO/vendor partners contracted to the study/region assigned
  • Leads and supports cross-functional study team to successfully manage external service providers
  • Leads/participates in clinical data review
  • Develop and operational design, planning, and strategy of clinical trial protocols and study and development plans
  • Creates/supports scenario planning and risk benefit analyses to make recommendations to align with corporate strategies
  • Contribute to models of performance excellence by identifying best practices, reviewing measurement systems, and improving operational efficiency
  • Manage relationships with vendor partners and suppliers in clinical programs to optimize delivery
  • Ensures efficient and effective communication and exchange of information across projects and reporting functions
  • May participate in Clinical submission activities
  • Supports the development and implementation of department-level SOPs for clinical trials and related activities
  • Interface with departments within and outside of Dianthus including Finance, Regulatory, Quality, and Tech Ops
  • Represent the company at Investigator Meetings

Skills

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI